1. The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics

   • Christopher R. Flowers
   • David Veenstra

   Leading Article 22 September 2012 Pages: 481 - 493

   

2. Pharmacogenomics and the Evolution of Healthcare

   • Mohan V. Bala
   • Gary A. Zarkin

   Commentary 22 September 2012 Pages: 495 - 498

   

3. Growth Hormone Therapy and Quality of Life in Adults and Children

   • Deborah J. Radcliffe
   • Joseph S. Pliskin
   • Leona Cuttler

   Review Article 22 September 2012 Pages: 499 - 523

   

4. An Economic Evaluation of Fluvastatin used for the Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention in the UK

   • Paul A. Scuffham
   • Stephen Chaplin

   Original Research Article 22 September 2012 Pages: 525 - 535

   

5. Psychometric and Utility-Based Measures of Health Status of Asthmatic Patients with Different Disease Control Level

   • Ágota Szende
   • Klas Svensson
   • Gyula Y. Berta

   Original Research Article 22 September 2012 Pages: 537 - 547

   

6. Outcome Measures for Pharmacoeconomics Education

   • Vittorio Maio
   • Jennifer H. Lofland

   Correspondence 22 September 2012 Pages: 549 - 550